Rafferty Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Sell
35,558
-404
-1% -$116K 0.03% 265
2025
Q1
$11.1M Sell
35,962
-2,122
-6% -$654K 0.05% 246
2024
Q4
$13.4M Sell
38,084
-12,872
-25% -$4.54M 0.05% 227
2024
Q3
$18.3M Sell
50,956
-14,487
-22% -$5.19M 0.06% 158
2024
Q2
$20.8M Buy
65,443
+27,713
+73% +$8.83M 0.08% 139
2024
Q1
$8.67M Buy
37,730
+584
+2% +$134K 0.03% 319
2023
Q4
$8.17M Sell
37,146
-2,378
-6% -$523K 0.03% 331
2023
Q3
$8.93M Buy
39,524
+3,210
+9% +$725K 0.05% 251
2023
Q2
$8.02M Buy
36,314
+6,523
+22% +$1.44M 0.05% 276
2023
Q1
$6.67M Buy
29,791
+1,019
+4% +$228K 0.05% 309
2022
Q4
$8M Sell
28,772
-2,282
-7% -$635K 0.07% 264
2022
Q3
$6.5M Buy
31,054
+13,707
+79% +$2.87M 0.07% 249
2022
Q2
$4.09M Sell
17,347
-13,563
-44% -$3.2M 0.04% 320
2022
Q1
$5.55M Buy
30,910
+2,946
+11% +$529K 0.03% 365
2021
Q4
$6.04M Buy
27,964
+13,146
+89% +$2.84M 0.03% 301
2021
Q3
$2.74M Buy
14,818
+253
+2% +$46.7K 0.02% 533
2021
Q2
$2.61M Sell
14,565
-6,312
-30% -$1.13M 0.02% 573
2021
Q1
$3.49M Buy
20,877
+14,155
+211% +$2.37M 0.02% 391
2020
Q4
$1.02M Sell
6,722
-12,633
-65% -$1.92M 0.01% 489
2020
Q3
$1.96M Buy
19,355
+11,084
+134% +$1.12M 0.02% 423
2020
Q2
$1M Buy
8,271
+3,127
+61% +$378K 0.01% 542
2020
Q1
$488K Sell
5,144
-38,625
-88% -$3.66M 0.02% 333
2019
Q4
$3.86M Sell
43,769
-36,553
-46% -$3.22M 0.06% 173
2019
Q3
$6.41M Buy
80,322
+17,126
+27% +$1.37M 0.1% 118
2019
Q2
$4.93M Buy
63,196
+17,735
+39% +$1.38M 0.09% 169
2019
Q1
$5.34M Buy
+45,461
New +$5.34M 0.09% 126
2018
Q1
Sell
-27,456
Closed -$4.06M 740
2017
Q4
$4.06M Buy
+27,456
New +$4.06M 0.07% 146
2016
Q4
Sell
-5,174
Closed -$611K 515
2016
Q3
$611K Sell
5,174
-11,868
-70% -$1.4M 0.02% 319
2016
Q2
$1.81M Buy
+17,042
New +$1.81M 0.12% 165